Token Cat Ltd (TC) Stock News

COMMENTARY: ENERGY WATCH: Flying blind  Reuters

Key Tronic Corporation (KTCC) shares fell 35.4% following Q4 fiscal 2026 results, which showed a GAAP net loss of $34.3 million despite improved gross margins. The company faced headwinds from supply chain credit constraints that delayed ~$10 million in shipments, along with a $28.4 million tax valuation allowance and $8.4 million in write-offs. However, management expects revenue growth and profitability recovery in fiscal 2027, supported by new program awards exceeding $60 million and restructuring initiatives including China exit and Vietnam expansion.

GreetEat Corporation (OTC: GEAT) announced a strategic roadmap for 2026-2027 aimed at strengthening its public-market infrastructure through PCAOB audit compliance, raising growth capital, expanding its ChefKart acquisition, pursuing additional acquisitions, and positioning itself for a future Nasdaq uplisting. ChefKart, a technology-enabled home-chef platform in India, reported 224% year-over-year revenue growth with $687,000 in recognized revenue for January-July 2026.

ResearchAndMarkets.com released a comprehensive analytical tool tracking CAR/TCR/TIL therapies in oncology, monitoring 870+ organizations and 2,370+ drugs across the pipeline. The tool provides competitive intelligence on leading developers including Gilead Sciences, Cellectis, MediGene, GenScript, and CARsgen Therapeutics, with 236 new therapies added in 2024/25 and over 1,700 BD&L contacts for partnership opportunities.

Intel closed at $91.67, up 1.8% but down 10.9% over the past month, underperforming the S&P 500. The company projects strong earnings growth with EPS expected at $0.39 (+69.57% YoY) and revenue of $16.36 billion (+19.85% YoY). However, Intel trades at a premium valuation with a Forward P/E of 61.41 versus the industry average of 35.61, and holds a Zacks Rank of #3 (Hold).

COMMENTARY: ENERGY WATCH: Back on the boil  Reuters

Deckers Outdoor Corporation's direct-to-consumer (DTC) business grew 13% to $352.8 million in Q1 fiscal 2027, significantly outpacing 2.2% wholesale growth. HOKA led the expansion with 17.3% revenue growth, while UGG contributed 5.7% growth. The stronger DTC channel mix helped expand gross margins by 60 basis points to 56.4%. Management projects continued significant DTC growth in fiscal 2027, with consolidated revenues expected between $5.86-$5.91 billion.

Semtech (SMTC), a $12 billion semiconductor supplier, is positioned as a pivotal player in AI infrastructure and optical interconnects. Following a strong earnings beat in August with EPS estimates raised over 30% for the current year and 50% for next year, the company benefits from demand for high-speed optical transceivers and data center solutions. Operating through three segments—Signal Integrity, Analog Mixed Signal, and IoT Systems—Semtech serves hyperscalers and industrial markets, with Greater China representing 47% of sales.

Hims & Hers Health (NYSE: HIMS) faces a securities class action lawsuit following an FTC complaint alleging the company engaged in deceptive health data sharing with advertising platforms like Meta and Snap, and violated billing regulations by charging consumers for prescriptions before medical consultations. The lawsuit, filed by the FTC alongside Utah and Los Angeles County, also accuses Hims of using dark patterns to prevent subscription cancellations. The stock dropped 14.7% ($4.32) on July 29, 2026, erasing over $970 million in market value.

Elastic has received a Zacks Rank #1 (Strong Buy) rating due to significant upward revisions in earnings estimates. The software developer is expected to earn $0.81 per share for the current quarter (+26.6% YoY) and $3.33 for the full year (+29.6% YoY). Analysts have raised consensus estimates substantially, with eight positive revisions in the past month and no negative revisions for the current year. The stock has gained 30% over the past four weeks.

TriCo Bancorp (TCBK), a finance sector company headquartered in Chico, is presented as an attractive dividend investment opportunity. The company offers a dividend yield of 2.73%, has increased its annualized dividend by 4.3% year-over-year, and maintains a conservative 35% payout ratio. With expected earnings growth of 15.68% for 2026 and a Zacks Rank of #2 (Buy), TCBK is positioned as both a compelling dividend play and growth investment opportunity.

The global air traffic control market is projected to grow from USD 11.83 billion in 2026 to USD 25.89 billion by 2035, with a CAGR of 8.14%. Growth is driven by rising aviation traffic, airport modernization, UAV integration, and adoption of AI, machine learning, digital towers, and satellite-based navigation. North America leads the market, while challenges include complex technology integration and workforce shortages.

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

On Holding (ONON) reported strong direct-to-consumer (DTC) growth of 26% in Q2 2026, reaching a record 45.7% of total sales. The shift toward DTC, combined with full-price discipline, lifted gross margins by 390 basis points to 65.4% despite U.S. tariffs. The company expects DTC to outpace wholesale in H2 2026 and projects 2026 gross margins of at least 65%. However, ONON shares have declined 25.6% over three months and carry a Zacks Rank #5 (Strong Sell) rating.

A comparison of Evertec (EVTC) and MasterCard (MA) in the Financial Transaction Services sector reveals that Evertec is the more attractive value investment. EVTC has a Zacks Rank of #2 (Buy) with improving earnings outlook, a forward P/E of 7.50, and a Value grade of A. MA has a Zacks Rank of #3 (Hold), a forward P/E of 29.98, and a Value grade of D, making it significantly more expensive on valuation metrics.

HUTCHMED announced positive Phase III SANOVO trial results showing that ORPATHYS® (savolitinib) combined with TAGRISSO® (osimertinib) demonstrated statistically significant progression-free survival improvements and encouraging overall survival benefits in treatment-naïve patients with MET-overexpressing EGFR-mutated NSCLC in China, extending the clinical value of the combination into the first-line setting.

Intel (INTC) closed at $89.47, down 2.85% in the latest trading session, underperforming the S&P 500's 0.25% loss. Despite the daily decline, the company is expected to report strong earnings with EPS projected at $0.39 (up 69.57% YoY) and revenue of $16.36 billion (up 19.85% YoY). However, Intel trades at a Forward P/E of 62.86, significantly above its industry average of 38.61, and holds a Zacks Rank #3 (Hold) rating with a slight downward revision in consensus EPS estimates.

HUTCHMED received conditional approval from China's NMPA for ATLED® (fanregratinib), a selective FGFR 1/2/3 inhibitor, for treating advanced intrahepatic cholangiocarcinoma with FGFR2 fusions/rearrangements in previously treated patients. The Phase II trial demonstrated an objective response rate of 42.5%, median PFS of 6.9 months, and median OS of 16.6 months, addressing a significant therapeutic gap in this aggressive cancer type.

Elastic reported Q1 FY2026 revenue of $478.11 million, up 15.1% year-over-year, beating the consensus estimate of $469.56 million by 1.82%. EPS came in at $0.70, significantly exceeding the $0.58 estimate by 20.69%. Subscription revenue grew 15.5% to $448.74 million, with Elastic Cloud revenue reaching $235.21 million, up 20.1% year-over-year. The stock has gained 23% over the past month but maintains a Zacks Rank #3 (Hold) rating.

Elastic reported Q3 2026 earnings of $0.70 per share, beating consensus estimates of $0.58 by 20.69%, with revenues of $478.11 million exceeding expectations by 1.82%. However, the stock has underperformed the S&P 500 year-to-date, gaining 5.1% versus the market's 12.1%. The company received a Zacks Rank #3 (Hold) rating, suggesting near-term performance in line with the market. DocuSign is expected to report results on September 3 with projected earnings of $1.08 per share, representing 17.4% year-over-year growth.

PesoRama Inc., a Canadian dollar store operator in Mexico under the JOi Dollar Plus brand, has upgraded from the Pink Limited Market to trade on OTCQX Best Market under ticker PSSOF. The company operates 43 stores across Mexico City and surrounding states, targeting cost-conscious consumers. The upgrade enables easier access for U.S. investors and reflects the company's expansion strategy.

ENERGY WATCH: Oil squeeze is just getting started  Reuters

Hims & Hers CEO Andrew Dudum spoke to CNBC about the FTC's lawsuit against the company, compounded GLP-1 drugs and AI.

Nord Precious Metals Mining Inc. announced that CEO Frank J. Basa will present at the OTCQB Virtual Investor Conference on August 5, 2026. The company operates TTL Laboratories in Ontario's Cobalt Camp and focuses on high-grade silver mining with integrated critical minerals recovery operations. Nord holds a 63 sq. km flagship Castle property with historical silver resources and maintains strategic interests in critical minerals through ownership in Coniagas Battery Metals Inc.

American Fusion Inc. (OTC: AMFN) announced successful completion of the initial phase of its Texatron™ Fusion Engine testing program at Texas Tech University. The company achieved key engineering objectives including successful operation of remote ignition and control systems, plasma switching demonstrations, and high-voltage operations. No measurable radiation was detected during testing. The company plans to continue with multiple phases of testing and expects to publish technical summaries and video updates in the coming weeks.

Law firm Brodsky & Smith announced investigations into four major merger transactions, examining whether the boards of MarketAxess Holdings, CBIZ, Sanara MedTech, and TriCo Bancshares breached fiduciary duties by failing to conduct fair processes and potentially underpaying shareholders. The firm is seeking shareholders to discuss potential class action lawsuits.

The FTC sued Hims & Hers over alleged health data sharing with Meta and Snap, billing practices and subscription cancellations.

Siemens Energy AG has upgraded from the Pink Limited Market to trade on OTCQX Best Market under symbols SMERY and SMEGF. The global energy technology company, which generates approximately 25% of U.S. electricity, sees the U.S. as its fastest-growing market at 29% of order intake in fiscal 2025, and announced a $1 billion domestic manufacturing investment in February 2026.

Vivos Inc. received FDA approval for its Investigational Device Exemption (IDE) to initiate a first-in-human feasibility study for RadioGel® at Mayo Clinic, targeting non-resectable papillary thyroid carcinoma patients. The company is expanding its animal therapy business with 17 certified clinics treating over 200 animals, establishing dual manufacturing facilities in the U.S. and India, and preparing for international clinical trial expansion with strong interest from multiple countries.

Following ARGAN's proposed merger with WDP announced on July 23, 2026, Standard & Poor's has placed ARGAN's 'BBB-' issuer credit rating on Positive CreditWatch, indicating a potential upgrade to 'BBB' upon merger completion in Q1 2027. The combined entity would benefit from increased scale, geographic diversification, reduced tenant concentration risk, and a stronger financial profile.